Guided Therapeutics (GTHP) Interest Coverage Ratio Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.80%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.94%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -35.05%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.28%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -4.98%
10 Guided Therapeutics - - 458,000.00 34.20%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 34.20%
Sep 30, 2025 21.92%
Jun 30, 2025 -20.17%
Mar 31, 2025 13.73%
Dec 31, 2024 2.88%
Sep 30, 2024 -85.04%
Jun 30, 2024 -69.89%
Mar 31, 2024 1.32%
Dec 31, 2023 -50.59%
Sep 30, 2023 -162.95%
Jun 30, 2023 -163.07%
Mar 31, 2023 -147.43%
Dec 31, 2022 -220.74%
Sep 30, 2022 -150.90%
Jun 30, 2022 -31.25%
Mar 31, 2022 -85.00%
Dec 31, 2021 -110.88%
Sep 30, 2021 5.74%
Jun 30, 2021 -2.40%
Mar 31, 2021 -55.88%
Dec 31, 2020 7.64%
Sep 30, 2020 54.12%
Jun 30, 2020 9.94%
Mar 31, 2020 28.48%
Dec 31, 2019 52.12%
Sep 30, 2019 44.99%
Jun 30, 2019 -18.72%
Mar 31, 2019 54.08%
Dec 31, 2018 71.51%
Sep 30, 2018 40.07%
Jun 30, 2018 30.57%
Mar 31, 2018 20.13%
Dec 31, 2017 14.64%
Sep 30, 2017 8.44%
Jun 30, 2017 66.37%
Mar 31, 2017 68.95%
Dec 31, 2016 69.75%
Sep 30, 2016 72.79%
Jun 30, 2016 84.36%
Mar 31, 2016 61.47%
Dec 31, 2015 29.96%
Sep 30, 2015 57.82%
Jun 30, 2015 56.55%
Mar 31, 2015 62.77%
Dec 31, 2014 70.71%
Sep 30, 2014 62.77%
Jun 30, 2014 -16.98%
Mar 31, 2014 -33.76%
Jun 30, 2013 -130.21%